The leaders of a Chilean late-stage human trial of the CoronaVac COVID-19 vaccine developed by China's Sinovac (SVA.O) on Thursday recommended a third dose of the jab to protect against the more contagious Delta variant.
A man receives a dose of Sinovac's CoronaVac coronavirus disease vaccine at a vaccination centre as the sanitary authority starts a vaccination campaign for under 30-year-old people in Santiago, Chile May 25, 2021. REUTERS/Ivan Alvarado/File Photo
on Thursday recommended a third dose of the jab to protect against the more contagious Delta variant. However, the study showed a drop-off in protective antibody levels after six months and Kalergis said he recommended the application of a third, "booster dose" to provide better protection against virus mutations.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What You Need to Know About COVID-19 Booster DosesThe what, when, why, where and how of additional COVID-19 vaccine doses
Read more »
Taiwan to get 2 mln more doses of COVID-19 vaccineAlmost 2 million more doses of COVID-19 vaccine will arrive in Taiwan on Thursday, consisting of direct purchases and a third donation from Japan, the government said, as the island ramps up inoculations, with domestic cases well under control.
Read more »
WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerableThe head of the World Health Organization slammed countries and regions that are ordering millions of booster doses of COVID-19 vaccines before many others...
Read more »
Haiti receives 1st COVID-19 vaccines but political unrest could delay distributionApproximately 500,000 doses of COVID-19 vaccine arrived in Haiti on Wednesday, but vaccine hesitancy and political unrest could delay distribution for weeks.
Read more »
What are the symptoms of Guillain-Barré syndrome? Should I still get the J&J vaccine?What to know about Guillain-Barré syndrome and Johnson & Johnson’s COVID-19 vaccine
Read more »
Pfizer COVID Vaccine 78% Effective in Pregnant WomenA new study found that two doses of Pfizer’s COVID-19 vaccine were 78% effective in preventing infection in pregnant women in Israel -- and no one reported severe adverse reactions to the shots.
Read more »